Molecular analysis of a candidate metastasis-associated gene, MTA1 : Possible interaction with histone deacetylase 1

Journal of Experimental and Clinical Cancer Research

Volumn 19, Issue 1, 2000, Pages 105-111

  Toh, Y ^a   Kuninaka, S ^a   Endo, K ^a   Oshiro, T ^a   Ikeda, Y ^a   Nakashima, H ^a   Baba, H ^a   Kohnoe, S ^a   Okamura, T ^a   Nicolson, G L ^c   Sugimachi, K ^b  

^a NATIONAL KYUSHU CANCER CENTER   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c INSTITUTE FOR MOLECULAR MEDICINE   (United States)

Author keywords

Chromatin remodeling; Histone deacetylase; Invasion and metastasis; MTA1; NURD complex; Transcriptional repression

Indexed keywords

HISTONE DEACETYLASE;

ANIMAL CELL; ARTICLE; CANCER GENETICS; HUMAN; IMMUNOFLUORESCENCE; LYMPH NODE METASTASIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION;

ANIMALS; CHROMATIN; COS CELLS; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTONE DEACETYLASES; HUMANS; NEOPLASM INVASIVENESS; PROTEINS; RATS; REPRESSOR PROTEINS; TRANSCRIPTION, GENETIC; TUMOR MARKERS, BIOLOGICAL;

EID: 0034071583     PISSN: 03929078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Nicolson G. L.: Cancer metastasis: tumor cell and host organ properties important in metastasis to specific secondary sites. Biochim. Biophys. Acta. 948: 175-224, 1988.
2. Liotta L. A.: Tumor invasion and metastases-role of the extracellular matrix: Rhoads Memorial Award lecture. Cancer Res. 46: 1-7, 1986.
3. Toh Y., Pencil S. D., Nicolson G. L.: A novel candidate metastasis-associated gene, mtal, differentially expressed in highly metastatic mammary adenocarcinoma cell lines. cDNA cloning, expression, and protein analyses. J. Biol. Chem. 269: 22958-63, 1994.
4. Toh Y., Pencil S. D., Nicolson G. L.: Analysis of the complete sequence of the novel metastasis-associated candidate gene, mta1, differentially expressed in mammary adenocarcinoma and breast cancer cell lines. Gene 159: 97-104, 1995.
5. Toh Y., Oki E., Oda S. et al.: Overexpression of the MTA1 gene in gastrointestinal carcinomas: Correlation with invasion and metastasis. Int. J. Cancer 74: 459-463, 1997.
6. Toh Y., Kuwano H., Mori M., Nicolson G. L., Sugimachi K.: Overexpression of metastasis-associated MTA1 mRNA in invasive oesophageal carcinomas. Br. J. Cancer 79: 1723-1726, 1999.
7. Nicolson G. L., Moustafa A. S.: Metastasis-Associated genes and metastatic tumor progression. In vivo 12: 579-578, 1998.
8. Paterno G. D., Li Y., Luchman H. A., Ryan P. J., Gillespie L. L.: cDNA cloning of a novel, developmentally regulated immediate early gene activated by fibroblast growth factor and encoding a nuclear protein. J. Biol. Chem. 272: 22591-25595, 1997.
9. Zhang Y., LeRoy G., Seelig H.-P., Lane W. S., Reinberg D The dermatomyosits-specific autoantigen Mi2 is a component of a complex containing histone deacetylase and nucleosome remodeling activities. Cell 95: 279-289, 1998.
10. Zhang Y., Ng H.-H., Erdjument-Bromage H., Tempst P., Bird A., Reinberg D.: Analysis of the NuRD subunits reveals a histone deacetylase core complex and a connection with DNA methylation. Genes Develop. 13: 1924-1935, 1999.
11. Futamura M., Nishimori H., Shiratsuchi T., Saji S., Nakamura Y., Tokino T.: Molecular cloning, mapping, and characterization of a novel human gene, MTA1-L1, showing homology to a metastasis-associated gene, MTA1. J. Hum. Genet. 44: 52-56, 1999.
12. Herman M. A., Ch'ng Q., Hettenbach S. M., Ratliff T. M., Kenyon C., Herman R. K.: EGL-27 is similar to a metastasis-associated factor and controls cell polarity and cell migration in C. elegans. Development 126: 1055-1064, 1999.
13. Solari R, Bateman A., Ahringer J.: The Caenorhabditis elegans genes egl-27 and egr-1 are similar to MTA1, a member of a chromatin regulatory complex, and are redundantly required for embryonic patterning. Development 126: 2483-2494, 1999.
14. Kleene R., Zdzieblo J., Wege K., Kern H.-F.: A novel zymogen granule protein (ZG29p) and the nuclear protein MTA1p are differentially expressed by alternative transcription initiation in pancreatic acinar cells of the rat. J. Cell. Sci. 112:2539-2548, 1999.
15. Ikeda S., Kishiba S., Yamamoto H., Murai H., Koyama S., Kikuchi A: Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3beta and beta-catenin and promotes GSK-3 beta-dependent phosphorylation of beta-catenin.. EMBO J. 17: 1371-1384, 1998.
16. Taunton J., Hassig C. A., Schreiber S. L.: A mammalian histone deacetylase related to the yeast transcriptional regulator Rpd3p. Science 272:408-411, 1996.
17. Ren R., Mayer B. J., Cicchetti P., Baltimore D.: Identification of a ten-amino acid proline-rich SH3 binding site. Science 259: 1157-61, 1993.
18. Yu H., Chen J. K., Feng S., Dalgarno D. C., Brauer A. W., Schreiber S. L.: Structural basis for the binding of proline-rich peptides to SH3 domains. Cell 76: 933-45, 1994.
19. Pawson T., Gish G. D.: SH2 and SH3 domains: from structure to function. Cell 71: 359-62, 1992.
20. Bar-Sagi D., Rotin D., Batzer A., Mandiyan V., Schlessinger, J.: SH3 domains direct cellular localization of signaling molecules. Cell 74: 83-91, 1993.
21. Seidel-Dugan C., Meyer B. E., Thomas S. M., Brugge J. S.: Effects of SH2 and SH3 deletions on the functional activities of wild-type and transforming variants of c-Src. Mol. Cell. Biol. 12: 1835-45, 1992.
22. Orkin S. H.: GATA-binding transcription factors in hema topoietic cells. Blood 80: 575-581, 1992.
23. Lyons G. E.: Vertebrate heart development. Cur. Opin. Genet. Develop. 6: 454-460, 1996.
24. Aasland R.: The SANT domain: putative DNA-binding domain in the SWI-SNF and ADA complexes, the transcriptional co-repressor N-CoR and TFIIIB. Trends Biochem. Sci. 21: 87-88, 1996.
25. Peterson C. L., Tamkun J. W.: The SWI-SNF complex : a chromatin remodeling machine?. Trends Biochem. Sci. 20: 143-146, 1995.
26. Horiuchi J., Silverman N., Marcus G. A., Guarente L.: DA3, a putative transcriptional adaptor, consists of two separable domains and interacts with ADA2 and GCN5 in a trimeric complex. Mol. Cell. Biol. 15: 1203-1209, 1995.
27. Horlein A. J., Naar A. M., Heinzel T. et al.: Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor. Nature 377: 397-404, 1995.
28. Kassavetis G. A., Nguyen S. T., Kobayashi R., Kumar A., Geiduschek E. P., Pisano M.: Cloning, expression, and function of TFC5, the gene encoding the B" component of the Saccharomyces cerevisiae RNA polymerase III transcription factor TFIIIB. Proc. Natl. Acad. Sci. USA 92: 9786-9790, 1995.
29. Xu Y., Wong J., Moreno G. T., Young M. K., Cote J., Wang W.: NURD, a Novel Complex with Both ATP-Dependent Chromatin-Remodeling and Histone Deacetylase Activities. Mol. Cell 2: 851-861, 1998.
30. Ptashne M.: How eukaryotic transcriptional activators work, Nature 335: 683-689, 1988.
31. Paterno G. D., Mercer F. C., Chayter J. J., Yang X., D. Robb, J., Gillespie L. L.: Molecular cloning of human er1 cDNA and its differential expression in breast tumours and tumour-derived cell lines. Gene 222: 77-82, 1998.
32. Tong J. K., Hassig C. A., Schnitzler G. R., Kingston R. E., Schreiber S. L.: Chromatin deacetylation by an ATP-dependent nucleosome remodelling complex.. Nature 395: 917-921, 1998.
33. Wade P. A., Jones P. L., Vermaak D., Wolffe A. P.: A multiple subunit Mi-2 histone deacetylase from Xenopus Laevis cofractionates with an associated Snf2 superfamily ATPase. Cur. Biol. 8: 843-846, 1998.
34. Yoshida M., Horinouchi S., Beppu T.: Trichostatin A and trapoxin: novel chemical probes for the role of histone acetylation in chromatin structure and function. Bioessays 17:423-430, 1995.
35. Airio A., Pukkala E., Isomaki H.: Elevated cancer incidence in patients with dermatomyositis: A population based study. J. Rheumatol. 22: 1300-1303, 1995.
36. Brehm A., Nielsen S. J., Miska E. A. et al: The E7 oncoprotein associates with Mi2 and histone deacetylase activity to promote cell growth. EMBO J. 18: 2449-2458, 1999.
37. Scanlan M. J., Chen Y. T., Williamson B. et al.: Characterization of human colon cancer antigens recognized by autologous antibodies. Int. J. Cancer 76: 652-658, 1998.